v3.23.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development costs $ 1,351,766 $ 1,160,737 $ 2,984,752 $ 4,241,203
General and administrative costs 1,138,748 607,113 1,981,594 1,834,966
Total operating expenses 2,490,514 1,767,850 4,966,346 6,076,169
Loss from operations (2,490,514) (1,767,850) (4,966,346) (6,076,169)
Other income (expense):        
Interest income 147,539 988 148,026 1,844
Interest expense (15,123) (305,161) (44,877)
Loss on debt extinguishment (2,261,581)
Other 13,230 7,118 18,304 47,646
Net loss (2,329,745) (1,774,867) (7,366,758) (6,071,556)
Preferred stock deemed dividend (1,323,535)
Net loss attributable to common stockholders $ (2,329,745) $ (1,774,867) $ (8,690,293) $ (6,071,556)
Loss per share, basic (in Dollars per share) $ (0.17) $ (0.52) $ (1.26) $ (1.78)
Weighted average number of shares of common stock, basic (in Shares) 13,660,627 3,410,103 6,899,984 3,410,103

Source